Cargando…

Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia

Plasma cell leukemia is a rare and aggressive plasma cell neoplasm that may either originate de novo (primary PCL) or by leukemic transformation of multiple myeloma (MM) to secondary PCL (sPCL). The prognosis of sPCL is very poor, and currently no standard treatment is available due to lack of prosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zatula, Alexey, Dikic, Aida, Mulder, Celine, Sharma, Animesh, Vågbø, Cathrine B., Sousa, Mirta M.L., Waage, Anders, Slupphaug, Geir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386695/ https://www.ncbi.nlm.nih.gov/pubmed/28038447 http://dx.doi.org/10.18632/oncotarget.14294

Ejemplares similares

Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells
por: Zub, Kamila Anna, et al.
Publicado: (2015)

Antibody cross-linking and target elution protocols used for immunoprecipitation significantly modulate signal-to noise ratio in downstream 2D-PAGE analysis
por: Sousa, Mirta ML, et al.
Publicado: (2011)

Identification of a novel, widespread, and functionally important PCNA-binding motif
por: Gilljam, Karin M., et al.
Publicado: (2009)

An Inverse Switch in DNA Base Excision and Strand Break Repair Contributes to Melphalan Resistance in Multiple Myeloma Cells
por: Sousa, Mirta M. L., et al.
Publicado: (2013)

UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation
por: Pettersen, Henrik Sahlin, et al.
Publicado: (2011)

MS-proteomics provides insight into the host responses towards alginate microspheres
por: Coron, Abba E., et al.
Publicado: (2022)

HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines
por: Iveland, Tobias S., et al.
Publicado: (2020)

Correction to: HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines
por: Iveland, Tobias S., et al.
Publicado: (2021)

ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA
por: Wollen, Kristian Lied, et al.
Publicado: (2021)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Divergent β-hairpins determine double-strand versus single-strand substrate recognition of human AlkB-homologues 2 and 3
por: Monsen, Vivi Talstad, et al.
Publicado: (2010)

Morphological Transformation of Myeloma Cells into Multilobated Plasma Cell Nuclei within 7 Days in a Case of Secondary Plasma Cell Leukemia That Finally Transformed as Anaplastic Myeloma
por: Fujimi, Akihito, et al.
Publicado: (2017)

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
por: Yang, Rui, et al.
Publicado: (2020)

Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study
por: Langseth, Øystein O., et al.
Publicado: (2022)

Changes in cellular signaling proteins in extracts from A549, H460, and U2OS cells treated with cisplatin or docetaxel
por: Petrovic, Voin, et al.
Publicado: (2017)

The human methyltransferase ZCCHC4 catalyses N(6)-methyladenosine modification of 28S ribosomal RNA
por: Pinto, Rita, et al.
Publicado: (2020)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients
por: Rampa, Christoph, et al.
Publicado: (2014)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

UDP‐glucose dehydrogenase expression is upregulated following EMT and differentially affects intracellular glycerophosphocholine and acetylaspartate levels in breast mesenchymal cell lines
por: Wang, Qiong, et al.
Publicado: (2022)

Long-Term Exposure to Nanosized TiO(2) Triggers Stress Responses and Cell Death Pathways in Pulmonary Epithelial Cells
por: Alswady-Hoff, Mayes, et al.
Publicado: (2021)

Genomic Uracil and Aberrant Profile of Demethylation Intermediates in Epigenetics and Hematologic Malignancies
por: Olinski, Ryszard, et al.
Publicado: (2021)

A ubiquitin-dependent signaling axis specific for ALKBH-mediated DNA dealkylation repair
por: Brickner, Joshua R., et al.
Publicado: (2017)

c-Met signaling promotes IL-6-induced myeloma cell proliferation
por: Hov, Håkon, et al.
Publicado: (2009)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
por: Sponaas, Anne Marit, et al.
Publicado: (2021)

Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA
por: Hagen, Lars, et al.
Publicado: (2008)

Multiple myeloma secondary to acute lymphoblastic leukemia: A case report
por: Hu, Tonglin, et al.
Publicado: (2019)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

A case of chronic eosinophilic leukemia with secondary transformation to acute myeloid leukemia
por: Hofmans, Mattias, et al.
Publicado: (2018)

Atrial Myocyte Function and Ca(2+) Handling Is Associated with Inborn Aerobic Capacity
por: Johnsen, Anne Berit, et al.
Publicado: (2013)

Psoriasis pathogenesis – Pso p27 constitutes a compact structure forming large aggregates
por: Lysvand, Hilde, et al.
Publicado: (2015)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
por: Westhrin, Marita, et al.
Publicado: (2018)

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
por: Murray, David L., et al.
Publicado: (2021)

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis
por: Brenne, Anne-Tove, et al.
Publicado: (2009)

Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma
por: Abildgaard, Niels, et al.
Publicado: (2023)

Secondary Plasma Cell Leukemia in a Recurrent Multiple Myeloma: Rare Case Scenario
por: Inamdar, Arati A, et al.
Publicado: (2020)

Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation
por: Yang, Chen-lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_56mohmve3c0t5ra1mjpt16vfec